May 28, 2025 12:00 PM GMT China Healthcare M Asia Pacific Insight China's CDMOs – What Are the Leading Indicators Telling Us? China's leading CDMOs (Contract Development and Manufacturing Organizations) have come in and out of the spotlight in the past five years as Covid-19 waxed and waned, and as geopolitics evolved. We recommend taking a look at current valuation levels, with WuXi XDC (2268.HK) our Top Pick. Key Takeaways Morgan Stanley Asia Limited+ Laurence Tam Equity Analyst In this report, we examine ...